CVS Health stock is trading -19.12% below its average target price of $65.06 after marking a 1.3% during today's morning session. Analysts are giving the Large-Cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $48.01 to $93.0 per share.
The stock has a very low short interest at 1.4%, and a short ratio of 1.18. The company's insiders own 0.13% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 82.5% of CVS Health's shares being owned by this investor type.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-09-30 | Vanguard Group Inc | 9% | 117,616,432 | $6,188,976,526 |
| 2024-09-30 | Blackrock Inc. | 8% | 104,549,511 | $5,501,395,157 |
| 2024-09-30 | Dodge & Cox Inc | 5% | 63,030,690 | $3,316,674,840 |
| 2024-09-30 | State Street Corporation | 4% | 56,527,909 | $2,974,498,511 |
| 2024-09-30 | Capital World Investors | 4% | 48,220,629 | $2,537,369,446 |
| 2024-09-30 | FMR, LLC | 2% | 28,327,041 | $1,490,568,867 |
| 2024-09-30 | Geode Capital Management, LLC | 2% | 26,361,673 | $1,387,151,205 |
| 2024-09-30 | Capital International Investors | 2% | 25,454,275 | $1,339,403,923 |
| 2024-09-30 | Morgan Stanley | 2% | 22,248,342 | $1,170,707,732 |
| 2024-06-30 | Norges Bank Investment Management | 1% | 14,901,126 | $784,097,234 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on CVS Health.
